Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease

• Váldodahkkit: Jurgen Sota (Dahkki), Donato Rigante (Dahkki), Piero Ruscitti (Dahkki), Antonella Insalaco (Dahkki), Paolo Sfriso (Dahkki), Salvatore de Vita (Dahkki), Rolando Cimaz (Dahkki), Giuseppe Lopalco (Dahkki), Giacomo Emmi (Dahkki), Francesco La Torre (Dahkki), Claudia Fabiani (Dahkki), Alma Nunzia Olivieri (Dahkki), Marco Cattalini (Dahkki), Daniele Cammelli (Dahkki), Romina Gallizzi (Dahkki), Maria Alessio (Dahkki), Raffaele Manna (Dahkki), Ombretta Viapiana (Dahkki), Micol Frassi (Dahkki), Manuela Pardeo (Dahkki), Armin Maier (Dahkki), Carlo Salvarani (Dahkki), Rosaria Talarico (Dahkki), Marta Mosca (Dahkki), Serena Colafrancesco (Dahkki), Roberta Priori (Dahkki), Maria Cristina Maggio (Dahkki), Carla Gaggiano (Dahkki), Salvatore Grosso (Dahkki), Fabrizio De Benedetti (Dahkki), Antonio Vitale (Dahkki), Roberto Giacomelli (Dahkki), Luca Cantarini (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background and Objective: Only a few studies have reported long-term efficacy of interleukin (IL)-1 inhibition in systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still disease (AOSD). Herein we report on the effectiveness of anakinra (ANA), expressed in terms of drug retention rate (DR...